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Abstract 
Background: Free amino acids and acylcarnitines circulating in the blood can be used for diagnosis for metabolic 
illness and imbalances. To date, the normal reference ranges of amino acids and acylcarnitines in horse peripheral 
blood have not been established. In this study, the concentrations of 12 amino acids and 26 acylcarnitines were deter‑
mined by tandem mass spectrometry in complete blood from 100 healthy horses (50 Quarter horses (QH) [23 males 
and 27 females] and 50 American Miniature horses (AMH) [15 males and 35 females]) with no signs of metabolic 
disease. The means and standard deviations were determined and data statistically analyzed.
Findings: Concentrations of short, medium, and long chain acylcarnitines were significantly higher in male AMH 
than in male QH. The concentrations of the amino acids alanine, arginine, glycine, proline (glycogenic), and leucine 
(ketogenic) were higher in the QH than in the AMH. Female AMH had higher concentrations of propionylcarnitine, 
leucine, proline, arginine, and ornithine than female QH.
Conclusions: Normal reference ranges of amino acids and acylcarnitines were established for AMH and QH. Signifi‑
cant differences were found in concentration of these compounds between breeds and gender.
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Findings
Analysis of free amino acids and acylcarnitines circulat-
ing in blood is a powerful diagnostic tool for metabolic 
illnesses and imbalances [1]; conditions that have an eco-
nomic impact in the equine sector [2]. Reference ranges 
for these compounds have been established for obese 
rats, adult canines and even for plants by tandem mass 
spectrometry (MS/MS) [3–5] and atypical myopathies 
have been identified in horses (Equus caballus) using 
this technology [6]. Metabolic disorders are common in 
horses, and can be categorized as disorders of carbohy-
drate metabolism [7], lipid disorders [8], purine disor-
ders [9], and primary disorders of electrolytic flux [10]. 
Diet [11] and metabolic disorders are important factors 
affecting amino acid and acylcarnitine concentrations in 
horses [12].
We hypothesized that concentrations of amino acids 
and acylcarnitines in the blood are different between 
Quarter horses (QH) and American Miniature horses 
(AMH). This study reports the concentrations of these 
compounds in peripheral blood of normal horse of both 
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gender and establishes normal reference ranges for these 
breeds.
The research protocol was approved by the Institu-
tional Committee for the Act # 2 (Approbation code 
FMVZ-CBA-002). A total of 100 clinically normal 
horses [50 QH (23 males and 27 females) and 50 AMH 
(15 males and 35 females)] from several stud farms and 
riding stables in the cities of Monterrey, Nuevo León 
and Cuatrociénegas, Coahuila, northeastern Mexico 
were selected. The horses were fed twice a day with 
dry forage (2.2  % of their body weight) and commer-
cial cereals, molasses, oilseeds, vitamins and minerals 
(0.5 % of their body weight), and water ad libitum. The 
horses were used in racing, rodeos, or kept as pets. Age 
and weight ranges are shown in detail in Additional 
file 1.
Complete blood was collected 3–5  h after first food 
ingestion in the morning from the jugular vein using a 
vacutainer tube with no anticoagulant and a 21G × 1.5″ 
size needle; posteriorly one drop of blood was placed on 
each of five filter paper circles (S&S 903, Whatman, Little 
Chalfont, UK) using a pipette. The filter papers were then 
dried for 3 h at room temperature avoiding exposure to 
sunlight.
Each sample was analyzed for 12 amino acids and 26 
acylcarnitines (Fig.  1). A 3.2  mm circle was obtained 
using a Wallac DBS Puncher (PerkinElmer, Waltham, 
MA, USA) from the dry filter paper. NeoBase non-deri-
vatized MS/MS kit (PerkinElmer) was used to obtain 
the metabolites of interest, following the manufacturer’s 
instructions. A solution included in the kit containing 
internal standards labeled with stable isotopes was used 
for quantification of the metabolites of interest. The 
prepared samples were analyzed by MS/MS (API 2000, 
ABSciex, Framingham, MA, USA) coupled to a micro-
pump and an autosampler (Series 2000, Perkin Elmer). 
Sample analysis was performed with multiple reaction 
monitoring using Analyst 1.6.2 Software (ABSciex) and 
the NeoBase database. The results were interpreted using 
Analyst 1.6.2 Software.
Statistical analysis was performed using R (http://www.
cran.r-project.org/). To normalize the raw measure-
ments, we set the sum of all values within a sample to 1. 
This was achieved by dividing each value by the sum of 
all values per sample. These normalized values were then 
converted to logarithms to handle extreme values. A t test 
was used to determine statistically significant differences 
between groups. Corrections of q-values were made for 
Fig. 1 Heat map representing concentrations of metabolites analyzed. Left panel shows data order by size. Right panel shows concentrations by 
gender. Horses are shown in columns and metabolites in rows, which are grouped by hierarchical clustering for clarity. Color code is shown. Arrows 
highlight significant changes
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multiple tests using a false discovery rate approach and 
P ≤  0.05 were considered as significant. For correlation 
analyses, absolute Pearson correlations ≥0.7 were used.
Normal reference ranges were established for 12 amino 
acids and 26 acylcarnitines in blood of AMH and QH. 
Mean values, standard deviation, maximum and minimum 
values for each metabolite are provided in Additional file 2 
for each breed and gender. Among the 38 metabolites 
(Fig. 1), the concentrations of 16 were significantly differ-
ent between the horse breeds (indicated by * Table 1).
Comparisons by gender between breeds (female 
quarters vs female miniatures, and the same for males) 
were statistically significant for both males and females 
(Table 1; Fig. 1), but not within the same breed. For male 
horses, concentrations of C2, C3, C5, C8, C14, C14:1, 
C:16 and C16:1 were significantly higher in AMH than 
in QH. Only C18:1 was higher in male QH than in male 
AMH. The concentrations of the amino acids Ala, Arg, 
Gly, Pro and Leu were significantly higher in QH than 
in AMH, while the concentrations of Val was higher in 
AMH than in QH. For the female horses, the concentra-
tions of C3, Leu, Pro and Arg were significantly higher in 
AMH than in QH. Inversely, Val and Orn were higher in 
QH than in AMH (Table 1; Fig. 1).
In the present study, horse breeds showed differences 
in acylcarnitine concentrations, which could be caused by 
variation in daily physical activity, individual genetics, or 
environmental factors. Diet is a factor that affects blood 
concentrations of amino acids, hormones, proteins, and 
other circulating compounds [11]. In the present study, 
horses were fed the same ration based on their individ-
ual weight, so the effects of diet on the obtained values is 
considered minimal. QH showed higher Leu concentra-
tions than AMH and conversely Val concentrations were 
higher in male AMH than in male QH. These differences 
may reflect metabolic differences between breeds. Analy-
sis of samples from other breeds may clarify this. If the 
differences depend on breed, this factor should be taken 
into account in the interpretation of the results for the 
possible diagnosis of metabolic disorders.
In conclusion, normal reference ranges were estab-
lished for amino acids and acylcarnitines in QH and 
AMH. The established ranges could be used to diagnose 
metabolic abnormalities that affect the performance 
of horses of high sporting and economic value. Positive 
results can be followed up with more specific testing for 
confirmation of the diagnosis.
Table 1 Overview of  analyzed metabolites in  American 
Miniature horses (AMH) (n = 50) and Quarter horses (QH) 
(n = 50)
The data were statistically compared according to breed (AMH vs. QH) and 
gender (♂ vs. ♀). See Abbreviations for metabolite abbreviations
* Represents a P value of P ≤ 0.05
Metabolites Compared groups
QH♀/QH♂ QH♀/AMH♀ QH♂/AMH♂ AMH♀/AMH♂
C0 0.87 0.44 0.73 0.93
C2 0.61 0.44 0.03* 0.86
C4 0.87 0.14 0.10 0.86
C6 0.61 0.44 0.83 0.96
C6DC 0.29 0.81 0.06 0.86
C8 0.52 0.81 0.01* 0.86
C8.1 0.99 0.07 0.35 0.86
C10 0.61 0.16 0.58 0.93
C10.1 0.80 0.45 0.14 0.86
C10.2 0.52 0.81 0.19 0.93
C12 0.36 0.81 0.06 0.86
C12.1 0.77 0.41 0.22 0.86
C14 0.80 0.06 0.01* 0.86
C14.1 0.61 0.15 0.04* 0.96
C14.2 0.61 0.81 0.14 0.86
C14OH 0.61 0.81 0.35 0.93
C16 0.80 0.15 0.01* 0.86
C16.1 0.61 0.20 0.01* 0.86
C16OH 0.90 0.98 0.74 0.86
C18 0.61 0.81 0.20 0.86
C18.1 0.61 0.29 0.01* 0.86
C18.2 0.61 0.98 0.38 0.93
C18OH 0.61 0.61 0.10 0.93
C5 0.61 0.41 0.03* 0.86
C5.1 0.61 0.41 0.12 0.86
C3 0.87 0.04* 0.03* 0.86
ALA 0.61 0.06 0.01* 0.93
ARG 0.89 0.00* 0.03* 0.86
CIT 0.87 0.45 0.07 0.86
GLY 0.36 0.45 0.03* 0.93
LEU 0.61 0.00* 0.00* 0.86
MET 0.89 0.43 0.78 0.86
ORN 0.97 0.01* 0.15 0.86
PHE 0.80 0.28 0.14 0.93
PRO 0.80 0.00* 0.01* 0.86
SA 0.61 0.23 0.22 0.86
TYR 0.61 0.11 0.38 0.86
VAL 0.87 0.00* 0.04* 0.86
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Abbreviations
Ala: alanine; AMH: American Miniature horses; Arg: arginine; C0: free carnitine; 
C4: butyrylcarnitine; C5: 1: tiglylcarnitine; C6: hexanoylcarnitine; C6DC: adipyl‑
carnitine; C8: 1: octenoylcarnitine; C10: decanoyl carnitine; C10: 1: decenoyl 
carnitine; C10: 2: decadienoyl carnitine; C12: dodecanoyl carnitine; C12: 1: 
dodecenoyl carnitine; C14: 2: tetradecadienoyl carnitine; C14OH: 3‑hydroxy‑
tetradecanoyl carnitine; C16OH: 3 hydroxy‑hexadecanoyl carnitine; C16: 1OH: 
3‑hydroxy‑hexadecenoyl carnitine; C18: octadecanoyl carnitine (estearoyl 
carnitine); C18: 2: octadecadienoyl carnitine (linoleyl carnitine); C18OH: 
3‑hydroxy‑octadecanoyl carnitine; C18: 1OH: 3‑hydroxy‑octadecenoyl carni‑
tine; Cit: citrulline; Gly: glycine; Leu: leucine; Met: methionine; Orn: ornithine; 
Phe: phenylalanine; Pro: proline; QH: Quarter horses; SA: succinylacetone; Tyr: 
tyrosine; Val: valine.
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